Premium
Elevation of lung surfactant phosphatidylcholine in mouse models of Sandhoff and of Niemann–Pick A disease
Author(s) -
Buccoliero R.,
Ginzburg L.,
Futerman> A. H.
Publication year - 2004
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1023/b:boli.0000042958.22066.6c
Subject(s) - sandhoff disease , sphingomyelin , niemann–pick disease , phospholipid , sphingolipid , phosphatidylcholine , pulmonary surfactant , hexosaminidase , biology , acid sphingomyelinase , endocrinology , medicine , biochemistry , enzyme , cholesterol , membrane
Summary: Sandhoff disease is caused by the defective activity of the lysosomal enzyme β‐hexosaminidase, resulting in accumulation of the glycolipids, GA 2 and GM 2 . Niemann–Pick A/B disease is caused by the defective activity of lysosomal acid sphingomyelinase resulting in sphingomyelin accumulation. Pulmonary complications have been observed in both diseases. We now demonstrate changes in phospholipid levels in pulmonary surfactant in mouse models of these diseases. In the Hexb mouse, a model of Sandhoff disease, lipid phosphate levels were elevated in surfactant from 3‐ and 4‐month‐old mice, which was mainly due to elevated levels of phosphatidylcholine. In the ASM mouse, a model of Niemann–Pick A disease, levels of the primary storage material, sphingomyelin, were elevated as expected, and levels of phosphatidylcholine and two other phospholipids were also significantly elevated in pulmonary surfactant and in lung tissue from 5‐, 6‐ and 7‐month‐old mice. These results suggest that changes in phospholipid levels and composition in lung surfactant might be a general feature of sphingolipid storage diseases, which may be in part responsible for the increased susceptibility of these patients to respiratory infections and lung pathology, often the main reason for the death of these patients.